pulmonary emboli - Nursing Case Study

Pathophysiology

• Primary mechanism: Thrombus formation, often originating in deep veins of the legs (DVT), dislodges and travels to the pulmonary vasculature, obstructing blood flow in the pulmonary arteries. This leads to impaired gas exchange and decreased oxygenation as blood flow to portions of the lung is reduced or stopped.

• Secondary mechanism: The obstruction leads to increased pulmonary vascular resistance, causing a strain on the right ventricle of the heart, which may lead to right ventricular dysfunction or failure due to the sudden increase in afterload.

• Key complication: As the right ventricle struggles to pump against the increased pressure, systemic hypotension and shock can occur, leading to multi-organ failure if not promptly managed.

Patient Profile

Demographics:

64-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Deep Vein Thrombosis (DVT)

• Current medications: Metformin, Lisinopril, Warfarin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of severe chest pain and shortness of breath

• Key symptoms: Tachycardia, hypotension, syncope, cyanosis, and leg swelling

• Vital signs: Blood pressure 85/55 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, oxygen saturation 82% on room air, temperature 37.2°C (99°F)

Section 1

As the healthcare team initiates a thorough initial assessment, the severity of the patient's condition becomes increasingly apparent. Upon auscultation, diminished breath sounds are noted in the lower lobes, alongside pronounced crackles, indicating potential pulmonary edema secondary to right ventricular failure. Her jugular venous distention is evident, a sign consistent with her suspected right heart strain. The extremities are notably cool and cyanotic, with significant swelling observed in the left leg, suggesting a likely source of the embolus. Despite supplemental oxygen administered at 10 liters via non-rebreather mask, her oxygen saturation only marginally improves to 85%, reflecting the extent of her compromised pulmonary circulation.

Concurrently, laboratory results reveal a markedly elevated D-dimer level, supporting the clinical suspicion of an acute thromboembolic event. Arterial blood gas analysis shows severe hypoxemia with a PaO2 of 55 mmHg and a respiratory alkalosis indicative of hyperventilation. Troponin levels are slightly elevated, raising concerns about right ventricular myocardial strain or infarction, compounded by the patient's pre-existing comorbidities. An emergent CT pulmonary angiogram confirms the presence of multiple large emboli occluding the right main and segmental pulmonary arteries, underscoring the critical need for immediate intervention to prevent further deterioration.

As the team deliberates on the best course of action, including the potential initiation of thrombolytic therapy, a sudden decline in the patient's hemodynamic stability occurs. She experiences a syncopal episode, with her blood pressure plummeting to 75/45 mmHg and heart rate escalating to 145 bpm, signaling progression to obstructive shock. The clinical focus shifts urgently to stabilizing her cardiovascular status while weighing the risks and benefits of aggressive anticoagulation versus surgical embolectomy, given her complex medical history and current presentation. This pivotal juncture demands advanced critical thinking and rapid decision-making to avert impending organ failure and guide the patient's subsequent management.

Section 2

As the healthcare team swiftly responds to the patient's acute hemodynamic instability, they initiate advanced resuscitative measures. Vasopressor support is commenced with norepinephrine to maintain adequate blood pressure and ensure perfusion to vital organs, while continuous cardiac monitoring is employed to assess for any arrhythmias due to the elevated heart rate and potential right ventricular strain. In parallel, the team discusses the urgent need for thrombolytic therapy, considering the severe obstruction caused by the emboli and the patient's deteriorating condition. Given her profound hypoxemia and risk of progressing to cardiac arrest, the decision is made to administer tissue plasminogen activator (tPA) despite the inherent bleeding risks, as the potential benefits outweigh the immediate threats posed by the massive pulmonary embolism.

During the administration of tPA, the patient is closely monitored for any signs of bleeding or adverse reactions. Fortunately, within the first hour of therapy, there is a slight improvement in her respiratory status; oxygen saturation rises to 89% with the continuation of high-flow oxygen. Her blood pressure stabilizes marginally, reaching 85/50 mmHg, and her heart rate decreases to 130 bpm, although she remains critically ill. Echocardiography is performed to further evaluate right ventricular function, revealing significant dilation and impaired contractility, consistent with acute cor pulmonale secondary to pulmonary embolism.

Despite these initial positive responses to intervention, a new complication emerges as the patient begins to complain of severe abdominal pain. Physical examination reveals a tense and distended abdomen, raising concerns about possible intra-abdominal bleeding, a known complication of thrombolytic therapy. Serial hemoglobin levels are checked, showing a drop from 13 g/dL to 9 g/dL within a few hours, indicating potential hemorrhage. The interdisciplinary team must now balance the life-saving benefits of ongoing anticoagulation with the urgent need to investigate and address the source of bleeding, while maintaining vigilant support for her compromised cardiovascular and respiratory systems. This development necessitates a reevaluation of her management strategy, requiring meticulous clinical judgment to navigate the intricacies of her multifaceted condition.

Section 3

As the team prioritizes the investigation of the suspected intra-abdominal bleeding, an urgent abdominal CT scan with contrast is ordered. While awaiting the imaging results, the patient's vital signs are closely monitored. Her blood pressure remains precariously low at 82/46 mmHg despite the ongoing norepinephrine infusion, and her heart rate, though slightly reduced, persists at a concerning 128 bpm. Her respiratory status shows a modest improvement with oxygen saturation now steady at 91% on high-flow oxygen, but she continues to exhibit signs of respiratory distress with labored breathing and accessory muscle use.

The CT scan reveals a large retroperitoneal hematoma, likely secondary to the thrombolytic therapy, which necessitates immediate intervention. Given the critical nature of her pulmonary embolism and the need for continued anticoagulation, the team faces a complex decision-making process. They must weigh the risks of ongoing bleeding against the danger of clot propagation. A multidisciplinary discussion ensues, involving hematology, surgery, and critical care specialists to determine the balance between aggressive management of the embolism and control of the hemorrhage.

To address the bleeding risk, the decision is made to temporarily reduce the anticoagulation dose and closely monitor her coagulation parameters, including PT, aPTT, and fibrinogen levels. Concurrently, the patient is transfused with packed red blood cells to address her dropping hemoglobin, now at 8.5 g/dL, and fresh frozen plasma to assist in stabilizing her coagulation profile. This strategy aims to stabilize her hemodynamic status while preparing for potential surgical intervention, should the hematoma expand or compromise vital structures. The team remains vigilant, knowing that her condition could rapidly deteriorate, requiring swift adjustments in her treatment plan as they navigate these intertwined complications.

Section 4

As the team carefully implements the modified anticoagulation strategy, they remain attentive to the patient's evolving clinical picture. Within hours, there is a noticeable shift in her status. Despite the transfusion and cautious reduction of anticoagulants, her blood pressure remains critically low, now dipping to 78/42 mmHg, and her tachycardia persists at 130 bpm. Her oxygen saturation shows a marginal decline to 89%, and she exhibits increased respiratory distress, with audible wheezes and diminished breath sounds over the right lung field. The team suspects the possibility of a collapsed lung segment or an evolving pleural effusion contributing to her respiratory compromise.

In response to these concerning developments, a repeat chest X-ray is expedited, revealing a moderate right-sided pleural effusion and signs of possible atelectasis. This prompts a thoracic ultrasound, which confirms the presence of fluid accumulation. Given her hemodynamic instability and the risk of further respiratory deterioration, the critical care team debates the merits of performing a therapeutic thoracentesis versus optimizing her fluid status and respiratory support further. They consider the balance of improving her respiratory mechanics against the potential for exacerbating her bleeding risk.

Meanwhile, her laboratory results return, showing a further drop in hemoglobin to 7.8 g/dL and an elevated aPTT, indicating a delicate coagulation balance. Hematology recommends administering cryoprecipitate to address her fibrinogen level, now critically low at 150 mg/dL, while continuing to monitor her coagulation profile closely. As the team deliberates the next steps, they acknowledge that her condition remains precarious, requiring ongoing assessment and agile clinical decision-making to navigate the intersecting challenges of her pulmonary, hematologic, and hemodynamic complexities.

Section 5

As the team decides to proceed with the therapeutic thoracentesis, they meticulously prepare for the procedure, recognizing the potential for both relief and risk. The interventional radiologist successfully aspirates 400 mL of straw-colored fluid from the right pleural space. Immediately following the procedure, there is a transient improvement in the patient's respiratory status; her oxygen saturation rises to 92%, and her respiratory rate decreases to 24 breaths per minute. However, this improvement is short-lived. Within the next hour, her blood pressure remains dangerously low at 82/46 mmHg, and she continues to exhibit tachycardia at 128 bpm.

New complications arise as the patient begins to exhibit signs of acute confusion and agitation, suggesting possible hypoperfusion or a neurological complication. A rapid neurological examination reveals that her Glasgow Coma Scale score has decreased to 12, with the patient responding inconsistently to verbal commands. These concerning signs prompt the team to initiate a STAT CT scan of the brain to rule out embolic stroke or intracranial bleeding, given her fragile coagulation status.

The laboratory results from the blood drawn pre-thoracentesis further complicate the picture. Her fibrinogen level, despite the administration of cryoprecipitate, remains low at 160 mg/dL, and her platelet count has decreased to 80,000/uL. Her aPTT remains elevated at 70 seconds. The hematology team is urgently consulted again to discuss the need for additional blood products, such as platelets or fresh frozen plasma, to stabilize her coagulation profile. As the team scrambles to address these new challenges, the patient's condition remains critical, necessitating continuous monitoring and rapid adjustments in her management plan to prevent further deterioration.